Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Lindemann

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|March 12, 2022
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classificationF Siegenthaler, K Lindemann, E Epstein, et al.
Cell|April 24, 2007
The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrestThomas Kaufmann, Lin Tai, Paul G Ekert, et al.
Histopathology|June 27, 2007
Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissueK Lindemann, J Resau, J Nährig, et al.
Differentiation; Research in Biological Diversity|August 10, 2000
Endothelial-like cells derived from human CD14 positive monocytesB Fernandez Pujol, F C Lucibello, U M Gehling, et al.
Molecular Biology of the Cell|November 10, 2017
Golgi stress-induced transcriptional changes mediated by MAPK signaling and three ETS transcription factors regulate MCL1 splicingJan Baumann, Tatiana I Ignashkova, Sridhar R Chirasani, et al.
Journal of Cell Science|May 25, 2017
TRAPPC13 modulates autophagy and the response to Golgi stressSilvia Ramírez-Peinado, Tatiana I Ignashkova, Bram J van Raam, et al.
Blood|December 9, 2008
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitorsKate F Whitecross, Amber E Alsop, Leonie A Cluse, et al.
Blood|April 23, 2009
The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacyLeigh Ellis, Michael Bots, Ralph K Lindemann, et al.
Gynecologic Oncology|June 29, 2024
NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancerM R Mirza, L Tandaric, J R Henriksen, et al.
The Journal of Biological Chemistry|December 3, 2004
A central role for Bid in granzyme B-induced apoptosisNigel J Waterhouse, Karin A Sedelies, Kylie A Browne, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|March 12, 2022
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classificationF Siegenthaler, K Lindemann, E Epstein, et al.
Cell|April 24, 2007
The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrestThomas Kaufmann, Lin Tai, Paul G Ekert, et al.
Histopathology|June 27, 2007
Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissueK Lindemann, J Resau, J Nährig, et al.
Differentiation; Research in Biological Diversity|August 10, 2000
Endothelial-like cells derived from human CD14 positive monocytesB Fernandez Pujol, F C Lucibello, U M Gehling, et al.
Molecular Biology of the Cell|November 10, 2017
Golgi stress-induced transcriptional changes mediated by MAPK signaling and three ETS transcription factors regulate MCL1 splicingJan Baumann, Tatiana I Ignashkova, Sridhar R Chirasani, et al.
Journal of Cell Science|May 25, 2017
TRAPPC13 modulates autophagy and the response to Golgi stressSilvia Ramírez-Peinado, Tatiana I Ignashkova, Bram J van Raam, et al.
Blood|December 9, 2008
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitorsKate F Whitecross, Amber E Alsop, Leonie A Cluse, et al.
Blood|April 23, 2009
The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacyLeigh Ellis, Michael Bots, Ralph K Lindemann, et al.
Gynecologic Oncology|June 29, 2024
NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancerM R Mirza, L Tandaric, J R Henriksen, et al.
The Journal of Biological Chemistry|December 3, 2004
A central role for Bid in granzyme B-induced apoptosisNigel J Waterhouse, Karin A Sedelies, Kylie A Browne, et al.
Pageof 7